GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prestige Consumer Healthcare Inc (NYSE:PBH) » Definitions » Shiller PE Ratio

Prestige Consumer Healthcare (Prestige Consumer Healthcare) Shiller PE Ratio

: 25.70 (As of Today)
View and export this data going back to 2005. Start your Free Trial

As of today (2024-04-18), Prestige Consumer Healthcare's current share price is $68.35. Prestige Consumer Healthcare's E10 for the quarter that ended in Dec. 2023 was $2.66. Prestige Consumer Healthcare's Shiller PE Ratio for today is 25.70.

The historical rank and industry rank for Prestige Consumer Healthcare's Shiller PE Ratio or its related term are showing as below:

PBH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.35   Med: 27.05   Max: 300
Current: 25.7

During the past years, Prestige Consumer Healthcare's highest Shiller PE Ratio was 300.00. The lowest was 16.35. And the median was 27.05.

PBH's Shiller PE Ratio is ranked worse than
52.82% of 515 companies
in the Drug Manufacturers industry
Industry Median: 24.57 vs PBH: 25.70

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Prestige Consumer Healthcare's adjusted earnings per share data for the three months ended in Dec. 2023 was $1.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $2.66 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Prestige Consumer Healthcare Shiller PE Ratio Historical Data

The historical data trend for Prestige Consumer Healthcare's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Consumer Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.24 19.58 20.14 20.05 25.64

Prestige Consumer Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.41 25.64 23.56 22.26 23.03

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prestige Consumer Healthcare Shiller PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Prestige Consumer Healthcare's Shiller PE Ratio falls into.



Prestige Consumer Healthcare Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Prestige Consumer Healthcare's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=68.35/2.66
=25.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prestige Consumer Healthcare's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Prestige Consumer Healthcare's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.06/129.4194*129.4194
=1.060

Current CPI (Dec. 2023) = 129.4194.

Prestige Consumer Healthcare Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.300 99.695 0.389
201406 0.320 100.560 0.412
201409 0.310 100.428 0.399
201412 0.400 99.070 0.523
201503 0.450 99.621 0.585
201506 0.490 100.684 0.630
201509 0.600 100.392 0.773
201512 0.530 99.792 0.687
201603 0.260 100.470 0.335
201606 -0.100 101.688 -0.127
201609 0.600 101.861 0.762
201612 0.590 101.863 0.750
201703 0.210 102.862 0.264
201706 0.630 103.349 0.789
201709 0.570 104.136 0.708
201712 5.880 104.011 7.316
201803 -0.750 105.290 -0.922
201806 0.650 106.317 0.791
201809 0.590 106.507 0.717
201812 0.730 105.998 0.891
201903 -2.680 107.251 -3.234
201906 0.650 108.070 0.778
201909 0.650 108.329 0.777
201912 0.750 108.420 0.895
202003 0.730 108.902 0.868
202006 0.860 108.767 1.023
202009 0.880 109.815 1.037
202012 0.810 109.897 0.954
202103 0.700 111.754 0.811
202106 1.140 114.631 1.287
202109 0.890 115.734 0.995
202112 0.990 117.630 1.089
202203 1.020 121.301 1.088
202206 1.090 125.017 1.128
202209 1.020 125.227 1.054
202212 1.040 125.222 1.075
202303 -4.830 127.348 -4.909
202306 1.060 128.729 1.066
202309 1.070 129.860 1.066
202312 1.060 129.419 1.060

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Prestige Consumer Healthcare  (NYSE:PBH) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Prestige Consumer Healthcare Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Prestige Consumer Healthcare's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Prestige Consumer Healthcare (Prestige Consumer Healthcare) Business Description

Traded in Other Exchanges
Address
660 White Plains Road, Tarrytown, NY, USA, 10591
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Executives
Mary Beth Fritz officer: Senior VP Quality & Regulatory 660 WHITE PLAINS RD, 2ND FL, TARRYTOWN NY 10591
Ronald M. Lombardi officer: Chief Executive Officer 660 WHITE PLAINS RD., TARRYTOWN NY 10591
James Darecca director C/O HAEMONETICS CORPORATION, 125 SUMMER STREET, BOSTON MA 02110
Christine Sacco officer: Chief Financial Officer C/O SMART BALANCE, INC., 115 WEST CENTURY ROAD, SUITE 260, PARAMUS NJ 07652
Adel Mekhail other: EVP, Marketing & Sales 660 WHITE PLAINS RD., 2ND FL, TARRYTOWN NY 10591
William P'pool officer: See Remarks 2400 WEST LLOYD EXPRESSWAY, EVANSVILLE IL 47721
Celeste A. Clark director C/O ADVANCEPIERRE FOODS HOLDINGS, INC., 9987 CARVER ROAD, BLUE ASH OH 45242
Christopher J Coughlin director
Natale S Ricciardi director C/O MORRIS COMMUNICATIONS CORP, 725 BROAD ST., AUGUSTA GA 30903
James M Jenness director PO BOX 3599, BATTLECREEK MI 49016-3599
John E Byom director 660 WHITE PLAINS RD., TARRYTOWN NY 10591
Sheila Hopkins director C/O WARNACO INC, 90 PARK AVENUE, NEW YORK NY 10016
Dawn M. Zier director 600 OFFICE CENTER DRIVE, FORT WASHINGTON PA 19034
Jeffrey Zerillo officer: Senior VP Operations 660 WHITE PLAINS RD, 2ND FL, TARRYTOWN NY 10591
Timothy Connors officer: Chief Marketing Officer 660 WHITE PLAINS RD., SUITE 205, TARRYTOWN NY 10591